Real-time Estimate Cboe Europe 05:31:46 2024-04-19 am EDT 5-day change 1st Jan Change
74.42 SEK -0.77% Intraday chart for Elekta AB -3.89% -9.92%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
ELEKTA : Elekta’s attractiveness reinforced Alphavalue
Elekta AB Announces Resignation of Kelly Londy, Member of the Board CI
ELEKTA : Q3 miss; mid-to-longer term prospects remain promising Alphavalue
Transcript : Elekta AB, Q3 2024 Earnings Call, Feb 29, 2024
Elekta AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024 CI
Nordic Stocks Closed Down Wednesday; Sinch Took Biggest Hit DJ
Nordic Shares Decreased Tuesday; Sinch Took Biggest Hit DJ
Elekta and Bristol Myers Squibb Partner on Digital Solution for Patients with Melanoma CI
Elekta, Bristol Myers Squibb Collaborate on Digital Platform for Melanoma Patients MT
Nordic Shares Closed Up Thursday; Autostore Holdings Topped Leaders DJ
ELEKTA : Another quarterly beat; but market disappointment with the Q3 outlook Alphavalue
European shares scale 2-mth high on energy, financial boost; eye strong monthly gains RE
Transcript : Elekta AB, Q2 2024 Earnings Call, Nov 30, 2023
Elekta AB Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023 CI
Elekta Receives Order for Approximately USD 40 Million from KIMS Hyderabad CI
Elekta AB Announces Composition of Nomination Committee CI
Elekta Enters $5.5 Million Deal to Acquire iCAD's Xoft Business MT
Elekta AB (OM:EKTA B) acquired Xoft, Inc. from iCAD, Inc. for $5.8 million. CI
Nordic Shares Closed Up Wednesday; ALK-Abello Series B Led Increases DJ
Chinese headwinds could be more severe than expected Alphavalue
ELEKTA : Taking into account possible challenges due to China's corruption crackdown Alphavalue
Elekta, International Atomic Energy Agency Enter Partnership to Boost Cancer Care in Underserved Countries MT
Elekta and the International Atomic Energy Agency Partner to Improve Access to Cancer Care in Underserved Countries CI
Nordic Stocks Decreased Friday; Surgical Science Sweden Fell Furthest DJ
US Futures Rise, European Stocks Mixed Ahead of Powell Speech DJ
Chart Elekta AB
More charts
Elekta publ AB is a Sweden-based human care company that develops and sells clinical solutions for the treatment of cancer and brain disorder. The Company offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer care. The Company has four product areas: Elekta Neuroscience, which develops solutions for the diagnosis and treatment of neurological diseases; Elekta Oncology, which creates clinical solutions for radiation therapy, such as linear accelerators, integrated imaging systems and clinical solutions for patient positioning and immobilization; Elekta Brachytherapy, which is engaged in the treatment of cancer through internal radiation, and Elekta Software, which develops software solutions for patient information, workflow management and treatment planning in oncology. The Company owns the service business of Asesores Electronicos Especializados SA de CV (AEESA).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
75 SEK
Average target price
83.42 SEK
Spread / Average Target
+11.22%
Consensus
  1. Stock Market
  2. Equities
  3. EKTA B Stock
  4. News Elekta AB
  5. Elekta Issues $165 Million of Sustainability-Linked Bonds